| Literature DB >> 25583649 |
Robert L Unckless1, Susan M Rottschaefer2, Brian P Lazzaro2.
Abstract
Individuals are genetically variable for the way in which they process nutrients and in the effects of dietary content on reproductive success, immunity, and development. Here, we surveyed genetic variation for nutrient stores (glucose, glycogen, glycerol, protein, triglycerides, and wet weight) in the Drosophila Genetic Reference Panel (DGRP) after rearing the flies on either a low-glucose or high-glucose diet. We found significant genetic variation for these nutritional phenotypes and identified candidate genes that underlie that variation using genome-wide associations. In addition, we found several significant correlations between the nutritional phenotypes measured in this study and other previously published phenotypes, such as starvation stress resistance, oxidative stress sensitivity, and endoplasmic reticulum stress, which reinforce the notion that these lines can be used to robustly measure related phenotypes across distinct laboratories.Entities:
Keywords: DGRP; Drosophila; glucose; glycogen; protein; triglyceride; weight
Mesh:
Year: 2015 PMID: 25583649 PMCID: PMC4349095 DOI: 10.1534/g3.114.016477
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Correlations between our nutritional indices and traits previously measured by other groups: principal components
| Phenotype | Starvation Stress Resistance | Chill Coma | Startle Response | Paraquat | MSB | ER Hazard Ratio | ER T50 | Male Reproductive Fitness | Lifespan | Male Aggression | Mating | Ethanol Tolerance |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Source | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 4 | 4 |
| Glucose | 0.069 | 0.043 | −0.057 | 0.076 | −0.134 | −0.073 | 0.303 | −0.043 | −0.048 | |||
| Glycogen | 0.099 | 0.163 | 0.183 | 0.224 | 0.212 | 0.041 | ||||||
| Glycerol | 0.079 | 0.005 | 0.008 | 0.012 | −0.013 | −0.020 | −0.050 | −0.227 | −0.235 | −0.175 | −0.225 | |
| Triglycerides | −0.071 | −0.081 | 0.003 | −0.045 | −0.107 | −0.038 | 0.067 | 0.042 | 0.245 | 0.244 | −0.129 | |
| Protein | −0.113 | −0.093 | −0.037 | −0.157 | −0.178 | 0.057 | −0.285 | −0.030 | 0.178 | |||
| Wet weight | 0.030 | −0.175 | 0.165 | −0.146 | 0.166 | 0.066 | 0.231 | |||||
| LGD PC1 | −0.090 | −0.143 | −0.132 | −0.136 | −0.058 | 0.148 | 0.066 | 0.111 | 0.115 | 0.124 | ||
| LGD PC2 | −0.052 | 0.152 | 0.114 | 0.072 | 0.037 | 0.184 | 0.113 | 0.242 | 0.288 | 0.050 | ||
| LGD PC3 | 0.013 | 0.152 | 0.090 | 0.214 | 0.058 | 0.021 | −0.280 | 0.155 | ||||
| LGD PC4 | −0.098 | −0.110 | 0 | −0.020 | −0.136 | 0.042 | 0.049 | 0.217 | −0.003 | 0.013 | 0.105 | |
| LGD PC5 | 0.087 | −0.070 | 0.093 | 0.016 | −0.065 | −0.052 | −0.054 | −0.027 | 0.158 | −0.130 | 0.021 | |
| HGD PC1 | 0.096 | 0.051 | −0.016 | 0.186 | −0.015 | 0.086 | 0.338 | 0.104 | −0.112 | |||
| HGD PC2 | −0.003 | −0.019 | −0.102 | −0.093 | −0.038 | −0.043 | 0.091 | −0.154 | 0.006 | −0.281 | −0196 | 0.120 |
| HGD PC3 | −0.035 | −0.035 | −0.068 | −0.070 | −0.079 | 0.046 | −0.232 | 0.292 | 0.166 | −0.042 | 0.025 | |
| HGD PC4 | 0.028 | −0.087 | −0.094 | 0.026 | −0.096 | −0.044 | 0.016 | −0.008 | −0.026 | −0.043 | −0.082 | |
| HGD PC5 | 0.135 | −0.116 | −0.001 | 0.141 | 0.096 | 0.163 | 0.059 | 0.102 | 0.144 | 0.253 | −0.086 |
All nutritional indices (protein, glucose, etc.) are values found when data from both diets were pooled. For correlation coefficients, cells in italics are P < 0.05 and cells in bold are P < 0.01. HGD, high-glucose diet; LGD, low -glucose diet; 1, Mackay ; 2, Jordan ; 3, Chow, Wolfner, and Clark 2013b; 4, Ayroles .
P < 0.05
P < 0.01.
P < 0.001.
Correlations performed with only 40 DGRP lines.
SNPs significantly associated with variation in nutritional indices at P < 10−6
| NI | Diet | SNP | Effect | MAF | Gene | FBgn | Type | Function | Reference | |
|---|---|---|---|---|---|---|---|---|---|---|
| Glucose | HGD | 3L.4811585 | 4.83E-07 | −0.020 | 0.394 | FBgn0051025 | Syn. | Cellularization | ||
| 3R.6404817 | 3.41E-07 | −0.022 | 0.222 | FBgn0001235 | Intron | Brain development | ||||
| 3R.23998828 | 9.64E-07 | −0.021 | 0.307 | CG34354 | FBgn0085383 | Intron | Nucleic acid binding | |||
| LGD | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Pooled | 3R.6290881 | 8.25E-07 | −0.023 | 0.075 | NA | NA | NA | NA | NA | |
| 3R.6404817 | 1.35E-07 | −0.015 | 0.226 | FBgn0001235 | Intron | Brain development | ||||
| 3R.6440408 | 9.67E-07 | −0.016 | 0.176 | FBgn0001235 | Intron | Brain development | ||||
| 3R.6446314 | 8.68E-07 | −0.016 | 0.179 | FBgn0001235 | Intron | Brain development | ||||
| 3R.6455818 | 3.57E-08 | −0.018 | 0.154 | FBgn0001235 | Intron | Brain development | ||||
| Glycerol | HGD | 2R.18726642 | 5.41E-07 | 0.014 | 0.297 | CG9825 | FBgn0034783 | Syn. | Transmembrane transport | |
| LGD | X.6541116 | 4.83E-07 | 0.013 | 0.224 | FBgn0029881 | Intron | Small body | |||
| X.6541138 | 2.35E-07 | 0.014 | 0.229 | FBgn0029881 | Intron | Small body | ||||
| X.6541155 | 7.14E-07 | 0.013 | 0.229 | FBgn0029881 | Intron | Small body | ||||
| X.6541215 | 2.24E-07 | 0.014 | 0.215 | FBgn0029881 | Intron | Small body | ||||
| Pooled | 2L.307423 | 1.16E-07 | −0.016 | 0.141 | FBgn0004611 | Intron | Lipid catabolic process | |||
| 3L.11508784 | 7.70E-07 | 0.011 | 0.353 | CG7512 | FBgn0036168 | Intron | Metal ion binding | |||
| 3R.14453686 | 1.54E-07 | −0.010 | 0.482 | FBgn0263974 | Intron | Protein autoubiquination | ||||
| Glycogen | HGD | 2R.7673484 | 4.56E-07 | −0.023 | 0.210 | FBgn0033652 | Intron | Fibroblast growth factor binding | ||
| 2R.17598285 | 2.15E-07 | 0.021 | 0.328 | CG30403 | FBgn0050403 | Intron | DNA binding | |||
| 2R.17598285 | 2.14E-07 | 0.021 | 0.338 | CG30403 | FBgn0050403 | Intron | DNA binding | |||
| LGD | 2L.8316116 | 4.93E-07 | −0.022 | 0.073 | CG7806 | FBgn0032018 | Syn. | Transmembrane transport | ||
| Pooled | 2L.11397732 | 4.66E-07 | −0.023 | 0.217 | NA | NA | NA | NA | ||
| Mean weight | HGD | NA | NA | NA | NA | NA | NA | NA | NA | |
| LGD | 2L.3261343 | 6.08E-07 | 56.1 | 0.321 | NA | NA | NA | NA | ||
| 2L.3271697 | 7.11E-07 | 53.6 | 0.420 | CG3347 | FBgn0031513 | 3′ UTR | Zinc ion binding | |||
| 3R.25948794 | 7.31E-07 | 60.9 | 0.239 | CG45072 | FBgn0266442 | Nonsyn. | Unknown | NA | ||
| 3R.25948812 | 8.9E-07 | 60.1 | 0.245 | CG45072 | FBgn0266442 | 5′ UTR | Unknown | NA | ||
| 3R.25952830 | 4.90E-09 | 84.3 | 0.150 | FBgn0051025 | Nonsyn. | Protein phosphatase inhibitor | ||||
| 3R.25952966 | 1.37E-08 | 83.2 | 0.143 | FBgn0051025 | Syn. | Protein phosphatase inhibitor | ||||
| 3R.25953010 | 9.67E-09 | 78.5 | 0.169 | FBgn0051025 | Nonsyn. | Protein phosphatase inhibitor | ||||
| 3R.25953104 | 5.00E-09 | 84.1 | 0.152 | FBgn0051025 | Syn. | Protein phosphatase inhibitor | ||||
| 3R.25953203 | 2.30E-08 | 76.4 | 0.155 | FBgn0051025 | Syn. | Protein phosphatase inhibitor | ||||
| 3R.25953305 | 4.36E-08 | 76.9 | 0.161 | FBgn0051025 | Syn. | Protein phosphatase inhibitor | ||||
| Pooled | 3R.25952830 | 2.90E-08 | 73.9 | 0.148 | FBgn0051025 | Nonsyn. | Protein phosphatase inhibitor | |||
| 3R.25952966 | 1.21E-07 | 71.5 | 0.141 | FBgn0051025 | Syn. | Protein phosphatase inhibitor | ||||
| 3R.25953010 | 3.49E-07 | 65.1 | 0.168 | FBgn0051025 | Nonsyn. | Protein phosphatase inhibitor | ||||
| 3R.25953104 | 5.44E-08 | 72.3 | 0.150 | FBgn0051025 | Syn. | Protein phosphatase inhibitor | ||||
| X.5877626 | 5.01E-07 | −48.3 | 0.423 | FBgn0029830 | Intron | Glutamate receptor binding; muscle attachment | ||||
| Protein | HGD | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| LGD | 2L.1888490 | 6.48E-07 | −0.016 | 0.298 | FBgn0031374 | Intron | Quinonprotein alcohol dehydrogenase activity | |||
| 2L.7008495 | 2.62E-07 | −0.021 | 0.149 | FBgn0031879 | 5′ UTR | Notch binding | ||||
| 3R.4370437 | 7.68E-07 | −0.020 | 0.145 | NA | NA | NA | NA | |||
| 3R.15771872 | 7.28E-07 | −0.018 | 0.216 | FBgn0038755 | Intron | Sulfotransferase | ||||
| Protein (cont.) | 3R.18325276 | 2.41E-07 | −0.023 | 0.140 | FBgn0038980 | Intron | Octopamine receptor activity | |||
| Pooled | 2R.17648180 | 6.69E-07 | −0.013 | 0.512 | NA | NA | NA | NA | ||
| 3L.6131752 | 5.82E-07 | 0.012 | 0.482 | Cpr65Av | FBgn0052405 | Down (571) | Insect cuticle protein | |||
| Lcp65Ae | FBgn0020640 | Up (534) | Insect cuticle protein | |||||||
| Triglycerides | HGD | X.20411124 | 3.85E-07 | −0.020 | 0.222 | FBgn0259162 | Intron | Cellular process | ||
| LGD | 2L.4905518 | 8.54E-07 | 0.025 | 0.353 | CG2837 | FBgn0031646 | Intron | Unknown | NA | |
| 2R.15064256 | 9.66E-07 | −0.025 | 0.331 | CG10737 | FBgn0034420 | Intron | Intracellular signal transduction | |||
| X.5445429 | 4.50E-07 | 0.033 | 0.188 | FBgn0263512 | Intron | DNA binding | ||||
| Pooled | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Effect, effect size of minor allele; SNPs labeled NA are not within 1000 bp of an annotated gene. Lines with all NAs indicate no SNPs met significance threshold; MAF, minor allele frequency.
SNPs significantly associated with variation in principal components of nutritional indices at P < 10−6
| PC | Diet | SNP | Effect | MAF | Gene | FBgn | Type | Function | Reference | |
|---|---|---|---|---|---|---|---|---|---|---|
| PC1 | HGD | 2L.15990382 | 9.79E-07 | −0.988 | FBgn0263331 | Down (435) | Nonprotein coding | |||
| X.16918901 | 9.24E-07 | 1.046 | FBgn0264739 | Down (923) | Unknown | NA | ||||
| PC2 | HGD | 3L.1235270 | 7.76E-08 | −1.015 | FBgn0053966 | 3′ UTR | Vitamin E binding | |||
| 3L.1235273 | 8.26E-07 | −0.927 | FBgn0053966 | 3′ UTR | Vitamin E binding | |||||
| 3L.2644168 | 9.74E-07 | 0.974 | FBgn0035358 | Up (744) | Unknown | NA | ||||
| 3L.17498584 | 9.88E-07 | 0.970 | FBgn0036732 | Intron | Organic anion transport | |||||
| PC3 | HGD | X.20411124 | 5.38E-07 | −0.977 | FBgn0259162 | Intron | DNA binding | |||
| PC4 | HGD | 3R.14205878 | 2.25E-07 | −0.976 | FBgn0038610 | Intron | Glucose/ribitol reductase | |||
| 3R.14206166 | 2.70E-08 | −1.016 | FBgn0038610 | Intron | Glucose/ribitol reductase | |||||
| 3R.14206170 | 2.34E-07 | −0.924 | FBgn0038610 | Intron | Glucose/ribitol reductase | |||||
| X.8316242 | 5.06E-07 | −1.630 | NA | NA | NA | NA | ||||
| PC5 | HGD | 2L.18537420 | 8.35E-07 | −0.817 | FBgn0085370 | Syn. | Phosphodiesterase | |||
| 2L.19068086 | 9.35E-07 | −1.693 | FBgn0032752 | Intron | Protein phosphorylation | |||||
| FBgn0032751 | Intron | Regulation of mitotic anaphase | ||||||||
| 3L.12761401 | 1.40E-07 | −1.800 | FBgn0052113 | Syn. | Vesicle-mediated transport | |||||
| 3R.22249607 | 4.98E-07 | −1.144 | FBgn0040606 | Down (813) | Unknown | NA | ||||
| PC1 | LGD | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| PC2 | LGD | 2L.14109774 | 3.30E-07 | 1.122 | 0.225 | FBgn0051769 | Syn. | Unknown | NA | |
| 2R.6893862 | 6.94E-07 | 1.126 | 0.196 | FBgn0040765 | Intron | DNA binding | ||||
| X.12603566 | 9.74E-07 | 0.889 | 0.373 | FBgn0263865 | Intron | Regulation of mitotic cell cycle | ||||
| PC3 | LGD | 3R.25503463 | 7.36E-07 | 0.884 | 0.302 | FBgn0039680 | Intron | Mitotic sister chromatin segregation | ||
| 3R.25504118 | 9.66E-07 | 1.009 | 0.269 | FBgn0039680 | Syn. | Mitotic sister chromatin segregation | ||||
| PC4 | LGD | 2R.4176279 | 6.74E-07 | 1.640 | 0.042 | NA | NA | NA | NA | NA |
| 3L.12262931 | 6.95E-07 | 0.666 | 0.442 | FBgn0036271 | 3′ UTR | Porphobolinogin synthase | ||||
| 3L.12412047 | 4.3E-07 | 2.33 | 0.021 | NA | NA | NA | NA | NA | ||
| 3L.13348431 | 1.72E-07 | 1.682 | 0.042 | FBgn0036348 | Down (391) | Unknown | NA | |||
| PC5 | LGD | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Effect, effect size of minor allele; MAF, minor allele frequency. SNPs labeled NA are not within 1000 bp of an annotated gene. Lines with all NAs indicate no SNPs met significance threshold.
Gene Ontology term enrichment analysis for SNPs with P < 10−4
| Index | Low-Glucose Diet | High-Glucose Diet | Both Diets Pooled | |||
|---|---|---|---|---|---|---|
| Glucose | Apoptosis | ( | Signal transduction | ( | Lipid transport | ( |
| DNA binding TF activity | ( | Enzyme activator activity | ( | Protein folding | ( | |
| Catalytic activity | ( | G-protein-coupled receptor | ( | |||
| Plasma membrane | ( | Intracellular | ( | |||
| Receptor activity | ( | |||||
| Glycerol | Mitochondrion organization | ( | DNA packaging | ( | RNA binding | ( |
| Ion transport | ( | Structural constituent of ribosome | ( | Translation | ( | |
| Transporter activity | ( | Ribosome | ( | Neurotransmitter transporter act. | ( | |
| Endopeptidase activity | ( | Plasma membrane | ( | Nucleo | ( | |
| Transport | ( | Transport | ( | Behavior | ( | |
| Defense response | ( | |||||
| Endocytosis | ( | |||||
| Apoptosis | ( | |||||
| Glycogen | Structural constituent of cytoskeleton | ( | Multicellular organismal development | ( | Lipid metabolic process | ( |
| Molecular function | ( | Lipid transport | ( | |||
| Transport | ( | |||||
| Mean wet weight | Protein kinase activity | ( | Intracellular | ( | Cytoskeleton organization | ( |
| Protein modification process | ( | Cytoskeleton organization | ( | Extracellular region | ( | |
| Response to stress | ( | Organelle development | ( | |||
| RNA binding | ( | Endopeptidase activity | ( | |||
| Cytosol | ( | Protein kinase activity | ( | |||
| Intracellular protein transport | ( | Peptidase activity | ( | |||
| Transcription factor binding | ( | Proteolysis | ( | |||
| RNA binding | ( | |||||
| Cytoskeleton | ( | |||||
| Protein modification process | ( | |||||
| DNA-dependent transcription | ( | |||||
| Protein | Extracellular region | ( | Cell death | ( | Centrosome | ( |
| Intracellular | ( | Sensory perception | ( | |||
| DNA binding | ( | Cytoskeleton organization | ( | |||
| Extracellular region | ( | Neurotransmitter transporter activity | ( | |||
| Molecular function | ( | |||||
| Triglyceride | Motor activity | ( | DNA binding TF activity | ( | Transporter activity | ( |
| Cell death | ( | Nucleus | ( | Centrosome | ( | |
| Cell communication | ( | Nucleic acid binding | ( | Cellular component | ( | |
| Intracellular | ( | DNA binding TF activity | ( | |||
| Transport | ( | |||||
| Ion transport | ( | |||||
| DNA binding | ( | |||||
“DNA binding TF activity” is “sequence-specific DNA binding transcription factor activity.”
“Nucleo” is “nucleobase, nucleoside, nucleotide, and nucleic acid metabolic process.